Delineating diseases by IMS-MS profiling of serum N-linked glycans

Dragan Isailovic, Manolo D. Plasencia, Maissa M. Gaye, Sarah T. Stokes, Ruwan T. Kurulugama, Vitara Pungpapong, Min Zhang, Zuzana Kyselova, Radoslav Goldman, Yehia Mechref, Milos V. Novotny, David E. Clemmer

Research output: Contribution to journalArticlepeer-review

45 Scopus citations


Altered branching and aberrant expression of N-linked glycans is known to be associated with disease states such as cancer. However, the complexity of determining such variations hinders the development of specific glycomic approaches for assessing disease states. Here, we examine a combination of ion mobility spectrometry (IMS) and mass spectrometry (MS) measurements, with principal component analysis (PCA) for characterizing serum N-linked glycans from 81 individuals: 28 with cirrhosis of the liver, 25 with liver cancer, and 28 apparently healthy. Supervised PCA of combined ion-mobility profiles for several, to as many as 10 different mass-to-charge ratios for glycan ions, improves the delineation of diseased states. This extends an earlier study [J. Proteome Res.2008, 7, 1109-1117] of isomers associated with a single glycan (S 1H 5N 4) in which PCA analysis of the IMS profiles appeared to differentiate the liver cancer group from the other samples. Although performed on a limited number of test subjects, the combination of IMS-MS for different combinations of ions and multivariate PCA analysis shows promise for characterizing disease states.

Original languageEnglish
Pages (from-to)576-585
Number of pages10
JournalJournal of Proteome Research
Issue number2
StatePublished - Feb 3 2012


  • ESI mass spectrometry
  • cancer
  • glycans
  • ion mobility
  • principal component analysis


Dive into the research topics of 'Delineating diseases by IMS-MS profiling of serum N-linked glycans'. Together they form a unique fingerprint.

Cite this